• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Acarix

0.26 SEK

-1.12 %

Less than 1K followers

ACARIX

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.12 %
-2.76 %
-7.03 %
-1.31 %
-5.54 %
-4.34 %
-51.57 %
-74.35 %
-96.42 %

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Read more
Market cap
319.4M SEK
Turnover
84.2K SEK
Revenue
7.36M
EBIT %
-652.31 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
ShowingAll content types

Forum discussions
On my journey in search of a new Revenio, in a country where vague Finland-Swedish was spoken and which was ruled by Carl XVI Gustaf, I came across a company called Acarix. And I’m not comparing this to be a new Revenio. For the diagnosis of coronary artery disease, a common basic...
9/8/2021, 5:11 AM
by Fisu
9
Expected SEK 79 million share issue now underway: https://acarix.com/wp-content/uploads/2021/11/acarixpralmeria-prospekteng.pdf
12/6/2021, 12:06 AM
by Pohjolan Eka
3
Tärkeimmät talousuutiset | Kauppalehti – 27 Jun 19 Acarix CADScor®System included in NICE guidelines (UK) Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä. Here’s a slightly older bulletin. An interesting product, which has...
9/8/2021, 7:32 AM
by PP2020
3
Interesting that the analyst firm is also an advisor.. Are they also an investor?
9/8/2021, 5:33 AM
by Yoda
3
Redeye’s website does have a Disclosures section for the company in question, which states whether Redeye owns the company. In this case, it does not. redeye.se Acarix Disclosures - Redeye Discover the latest equity research on Acarix.
9/8/2021, 2:45 PM
by Llopardi
2
PubMed Economic Analysis of the CADScor System for Ruling Out Coronary Artery... The CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the...
9/8/2021, 5:40 AM
by PP2020
2
News from America has arrived; I don’t know how to post it here. Thanks in advance
10/27/2021, 11:02 AM
by Hollitupa
1
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.8
2026

Interim report Q2'26

5.11
2026

Interim report Q3'26

11.2
2027

Annual report '26

Regulatory press release17.06.2026, 16.30

Announcement from the annual general meeting in Acarix AB

Acarix
Regulatory press release16.06.2026, 19.00

Proposals of the Nomination Committee for the Annual General Meeting of Acarix AB (publ) on June 17, 2026

Acarix
Press release19.05.2026, 11.12

Redeye: Acarix (Q1 Review): Continued US traction and improved cost base

Acarix

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release18.05.2026, 22.30

NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB

Acarix
Regulatory press release18.05.2026, 08.00

Acarix Publishes Interim Report, January – March 2026

Acarix
Regulatory press release04.05.2026, 14.23

Acarix Changes Publication Date for Q1 2026 Interim Report

Acarix
Regulatory press release15.04.2026, 13.00

Acarix AB’s Annual Report 2025

Acarix
Press release07.04.2026, 13.00

ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM'S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS

Acarix
Press release13.02.2026, 13.05

Redeye: Acarix (Q4 review): A solid end to 2025

Acarix
Regulatory press release12.02.2026, 08.00

Acarix Publishes Year-End Report 2025

Acarix
Press release11.02.2026, 09.20

Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System

Acarix
Press release04.02.2026, 09.20

Acarix Receives EU MDR Certification for the CADScor®System

Acarix
Regulatory press release08.12.2025, 08.47

ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION

Acarix
Press release06.11.2025, 08.45

Invitation to presentation of Acarix´s third quarter 2025 report

Acarix
Regulatory press release06.11.2025, 08.00

Acarix Publishes Interim Report, Third quarter 2025

Acarix
Regulatory press release27.10.2025, 15.35

Announcement from the general meeting in Acarix AB

Acarix
Regulatory press release24.10.2025, 15.15

Acarix AB changes Certified Adviser to Tapper Partners AB

Acarix
Press release17.10.2025, 08.30

Acarix responds to G-BA decision on reimbursement in the German market

Acarix
Regulatory press release09.10.2025, 12.15

NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACARIX AB

Acarix
Press release07.10.2025, 09.31

Acarix CADScor® System Gains HealthChoice Reimbursement Coverage

Acarix